Literature DB >> 902675

Recording of drug prescriptions in the county of Jämtland, Sweden. II. Drug exposure of pregnant women in relation to course and outcome of pregnancy.

G Boethius.   

Abstract

Prescription data have been analysed in order to study drug exposure of women before, during and after pregnancy as compared to non-pregnant controls. During full term pregnancy (n = 341) drug exposure increased markedly, mostly due to prescription of drugs such as iron and vitamins. Excluding these drugs, the increase was statistically significant only for one third of the women whose case records revealed some intercurrent disease during pregnancy. Women whose pregnancy ended in a spontaneous abortion (n = 29) did not differ significantly from controls in terms of drug exposure before, during or after pregnancy. In an induced abortion group (n = 60), drug exposure was more pronounced before pregnancy than in the other pregnant patients or controls. On comparing the drug history obtained from delivery records with that obtained in this study it was found that only diuretics and urinary tract chemotherapeutics had been noted fairly consistently in the former records.

Entities:  

Mesh:

Year:  1977        PMID: 902675     DOI: 10.1007/bf00561403

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  10 in total

1.  Exposure to drugs and other possibly harmful factors during the first trimester of pregnancy. Comparison of two prospective studies performed in Sweden 10 years apart.

Authors:  S Kullander; B Källén; B Sandahl
Journal:  Acta Obstet Gynecol Scand       Date:  1976       Impact factor: 3.636

2.  A STUDY OF INTERCURRENT CONDITIONS OBSERVED DURING PREGNANCY.

Authors:  C H PECKHAM; R W KING
Journal:  Am J Obstet Gynecol       Date:  1963-11-01       Impact factor: 8.661

3.  Recording of drug prescriptions in the county of Jämtland, Sweden. I. Methodological aspects.

Authors:  G Boethius; F Wiman
Journal:  Eur J Clin Pharmacol       Date:  1977-08-17       Impact factor: 2.953

4.  The susceptibility of the fetus and child to chemical pollutants. How environmental effects on child health are recognized.

Authors:  R W Miller
Journal:  Pediatrics       Date:  1974-05       Impact factor: 7.124

5.  Epidemiology of drugs taken by pregnant women: drugs that may affect the fetus adversely.

Authors:  J O Forfar; M M Nelson
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

6.  Abnormal ontogeny in young rabbits after chronic administration of haloperidol to the nursing mothers.

Authors:  P Lundborg
Journal:  Brain Res       Date:  1972-09-29       Impact factor: 3.252

7.  The use of medicines before and during pregnancy - preliminary results from an epidemiological study of congenital defects.

Authors:  J H Medalie; D Serr; H N Neufeld; M Brown; N Berandt; M Sternberg; P Sive; S Schoenfeld; Z Fuchs; S Karo
Journal:  Adv Exp Med Biol       Date:  1972       Impact factor: 2.622

Review 8.  Environmental teratogens of man.

Authors:  R W Smithells
Journal:  Br Med Bull       Date:  1976-01       Impact factor: 4.291

9.  Drugs ingested by pregnant women.

Authors:  R M Hill
Journal:  Clin Pharmacol Ther       Date:  1973 Jul-Aug       Impact factor: 6.875

10.  A prospective study of drugs and pregnancy. I. Psychopharmaca.

Authors:  S Kullander; B Källén
Journal:  Acta Obstet Gynecol Scand       Date:  1976       Impact factor: 3.636

  10 in total
  11 in total

Review 1.  Pharmaco-epidemiological perspectives.

Authors:  U Bergman
Journal:  Pharm Weekbl Sci       Date:  1989-10-20

2.  National Variation in Use of Immunosuppression for Kidney Transplantation: A Call for Evidence-Based Regimen Selection.

Authors:  D A Axelrod; A S Naik; M A Schnitzler; D L Segev; V R Dharnidharka; D C Brennan; S Bae; J Chen; A Massie; K L Lentine
Journal:  Am J Transplant       Date:  2016-03-31       Impact factor: 8.086

3.  Drug use in pregnancy: an overview of epidemiological (drug utilization) studies.

Authors:  M Bonati; R Bortolus; F Marchetti; M Romero; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Information on drug use in pregnancy from the Viewpoint Regional Drug Information Centre.

Authors:  O Kasilo; M Romero; M Bonati; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

5.  Drug use in pregnancy: a comparative appraisal of data collecting methods.

Authors:  L T de Jong-van den Berg; C M Waardenburg; F M Haaijer-Ruskamp; M N Dukes; H Wesseling
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

6.  Associations of pre-transplant prescription narcotic use with clinical complications after kidney transplantation.

Authors:  Krista L Lentine; Ngan N Lam; Huiling Xiao; Janet E Tuttle-Newhall; David Axelrod; Daniel C Brennan; Vikas R Dharnidharka; Hui Yuan; Mustafa Nazzal; Jie Zheng; Mark A Schnitzler
Journal:  Am J Nephrol       Date:  2015-03-27       Impact factor: 3.754

7.  Novel methods for tracking long-term maintenance immunosuppression regimens.

Authors:  Paula M Buchanan; Mark A Schnitzler; Daniel C Brennan; Nino Dzebisashvili; Lisa M Willoughby; David Axelrod; Paolo R Salvalaggio; Kevin C Abbott; Thomas E Burroughs; Krista L Lentine
Journal:  Clin J Am Soc Nephrol       Date:  2007-12-12       Impact factor: 8.237

8.  Effects of drug administration in pregnancy on children's school behaviour.

Authors:  L Stika; K Elisová; L Honzáková; H Hrochová; H Plechatová; J Strnadová; B Skop; J Svihovec; M Váchova; O Vinar
Journal:  Pharm Weekbl Sci       Date:  1990-12-14

9.  Pharmaco-morbidity linkage: a feasibility study comparing morbidity in two pharmacy based exposure cohorts.

Authors:  R M Herings; A Bakker; B H Stricker; G Nap
Journal:  J Epidemiol Community Health       Date:  1992-04       Impact factor: 3.710

10.  Use of psychotropic drugs during pregnancy. A report of the international co-operative drug use in pregnancy (DUP) study. Collaborative Group on Drug Use in Pregnancy (CGDUP).

Authors:  F Marchetti; M Romero; M Bonati; G Tognoni
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.